Device Atlas

I Bradykinin & Anti-Bradykinin Antiserum

FDA 510(k) K790362 · Cambridge Nuclear Corp.

Substantially Equivalent

510(k) numberK790362

Submission

Device name: I Bradykinin & Anti-Bradykinin Antiserum
Applicant: Cambridge Nuclear Corp.
Mchenry, IL, US
Received: February 22, 1979
Decision date: April 23, 1979
Decision: Substantially Equivalent (SESE)
Type: Traditional 510(k)

Official FDA 510(k) record

Device classification

No product code recorded.

More from Cambridge Nuclear Corp.

510(k)	Device	Decision
K811380	Estriol KitCGI · Traditional	06/09/1981SE
K810804	Progesterone KitJLS · Traditional	04/01/1981SE
K790008	I EstriolCGI · Traditional	02/26/1979SE
K790007	I TestoteroneCDZ · Traditional	02/26/1979SE

Questions and answers

When was I Bradykinin & Anti-Bradykinin Antiserum cleared by the FDA?

I Bradykinin & Anti-Bradykinin Antiserum (K790362) received a 510(k) decision of Substantially Equivalent on April 23, 1979, 60 days after the submission was received.